| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Former Chief Medical Officer | Chief Medical Officer
1 company
Obrien Christopher Flint is a Former Chief Medical Officer at NEUROCRINE BIOSCIENCES INC. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $7.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2018 | NBIX Neurocrine Biosciences INC | Former Chief Medical Officer | Sell | 2,613 | $83.18 | $217,341.46 | -2.4% | |
| Jan 16, 2018 | NBIX Neurocrine Biosciences INC | Chief Medical Officer | Sell | 1,750 | $79.14 | $138,499.03 | -3.3% | |
| Nov 2, 2017 | NBIX Neurocrine Biosciences INC | Chief Medical Officer | Sale+OE | 52,817 | $69.71 | $3,681,640.68 | -35.0% | |
| Oct 2, 2017 | NBIX Neurocrine Biosciences INC | Chief Medical Officer | Sale+OE | 6,925 | $61.04 | $422,702.00 | -12.4% | |
| Sep 5, 2017 | NBIX Neurocrine Biosciences INC | Chief Medical Officer | Sale+OE | 52,817 | $57.50 | $3,036,977.50 | -51.9% | |
| Jul 27, 2017 | NBIX Neurocrine Biosciences INC | Chief Medical Officer | Sale+OE | 8,734 | $50.00 | $436,700.00 | -15.1% | |
| May 18, 2017 | NBIX Neurocrine Biosciences INC | Chief Medical Officer | Sale+OE | 105,634 | $53.32 | $5,632,404.88 | -68.3% | |
| Apr 12, 2017 | NBIX Neurocrine Biosciences INC | Chief Medical Officer | Sell | 13,065 | $50.42 | $658,773.93 | -11.7% | |
| Feb 6, 2017 | NBIX Neurocrine Biosciences INC | Chief Medical Officer | Sell | 1,206 | $43.17 | $52,063.02 | -3.2% | |
| Feb 3, 2017 | NBIX Neurocrine Biosciences INC | Chief Medical Officer | Sell | 1,500 | $42.50 | $63,750.00 | -4.1% |